Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis -: An economic evaluation

被引:95
|
作者
van den Belt, AGM
Bossuyt, PMM
Prins, MH
Gallus, AS
Büller, HR
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DE Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Ctr Haemostas Thrombos Atheroscler & Inflamm Res, NL-1100 DE Amsterdam, Netherlands
[3] Flinders Med Ctr, Adelaide, SA, Australia
关键词
D O I
10.1055/s-0037-1614975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two clinical trials in patients with acute deep venous thrombosis have indicated that the outpatient management with fixed-dose, subcutaneous low-molecular-weight heparin is at least as effective and safe as inpatient treatment with unfractionated intravenous heparin with respect to recurrent venous thromboembolism and major bleeding. We performed an economic evaluation alongside one of these trials to assess the cost consequences of the outpatient management strategy. Data were collected through case record forms, complemented by a prospective questionnaire in 78 consecutive patients, interviews with health care providers, and hospital data bases. Our study demonstrated that seventy-five percent of patients allocated to low-molecular-weight heparin received treatment either entirely al home or after a brief hospital stay. Fifteen percent of these patients required professional domiciliary care. Within-centre comparisons of resource utilisation in terms of natural units showed that outpatient management with low-molecular-weight heparin reduced the average number of hospital days in the initial treatment period in nine centres by 59 percent (95% CI: 43 to 71 percent) accompanied by a limited increase in outpatient and professional domiciliary care. The average reduction in hospital days at the end of follow up was 40 percent (95% CI: 25 to 54 percent). A cost-minimisation analysis, focusing on resource utilisation directly related to the treatment of deep venous thrombosis and associated costs in one centre demonstrated a cost reduction of 64 percent (95% CI: 56 to 72 percent) with the outpatient management with low-molecular-weight heparin. These data suggest that outpatient management of patients with proximal venous thrombosis using low-molecular-weight heparin reduces resource utilisation and total treatment cost. Implementation should be preceded by a cautious evaluation of a potential cost shifting and organisational prerequisites.
引用
收藏
页码:259 / 263
页数:5
相关论文
共 50 条
  • [31] Safely Ruling Out Deep Venous Thrombosis in Primary Care
    Buller, Harry R.
    ten Cate-Hoek, Arina J.
    Hoes, Arno W.
    Joore, Manuela A.
    Moons, Karel G. M.
    Oudega, Ruud
    Prins, Martin H.
    Stoffers, Henri E. J. H.
    Toll, Diane B.
    van der Velde, Eit F.
    van Weert, Henk C. P. M.
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (04) : 229 - U13
  • [32] Characteristics of provoked deep venous thrombosis in a tertiary care center
    Brownson, Kirstyn E.
    Brahmandam, Anand
    Huynh, Nancy
    Reynolds, Jesse
    Fares, Wassim H.
    Lee, Alfred Ian
    Dardik, Alan
    Chaar, Cassius Iyad Ochoa
    [J]. JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2017, 5 (04) : 477 - 484
  • [33] DEEP VENOUS THROMBOSIS IN THE SURGICAL INTENSIVE-CARE UNIT
    HOYT, DB
    SWEGLE, JR
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 1991, 71 (04) : 811 - 830
  • [34] D-dimer and calf circumference in the evaluation of outpatient deep venous thrombosis
    Johanning, JM
    Franklin, DP
    Thomas, DD
    Elmore, JR
    [J]. JOURNAL OF VASCULAR SURGERY, 2002, 36 (05) : 877 - 880
  • [35] Cost for inpatient care of venous thrombosis -: A trial of enoxaparin vs standard heparin
    de Lissovoy, G
    Yusen, RD
    Spiro, TE
    Krupski, WC
    Champion, AH
    Sorensen, SV
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (20) : 3160 - 3165
  • [36] ESTABLISHING STANDARDS FOR OUTPATIENT AND INPATIENT CARE
    BOGATYREV, ID
    [J]. INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1972, 2 (01): : 45 - 49
  • [37] THE TRANSITION FROM INPATIENT TO OUTPATIENT CARE
    BERMAN, AL
    [J]. SUICIDE AND LIFE-THREATENING BEHAVIOR, 1994, 24 (03) : 302 - 307
  • [38] Balancing Inpatient and Outpatient Oncology Care
    McDevitt, Rachel
    McLean, John
    Olsen, Mikaela
    Souza, Beth
    Halpern, Anna
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22
  • [39] Management of acute proximal deep vein thrombosis - Pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin
    Spyropoulos, AC
    Hurley, JS
    Ciesla, GN
    de Lissovoy, G
    [J]. CHEST, 2002, 122 (01) : 108 - 114
  • [40] Economic issues in the treatment and prevention of deep vein thrombosis from a managed care perspective
    de Lissovoy, G
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2001, 7 (17): : S535 - S544